WO2002034768A3 - Polypeptides and polynucleodides from haemophilus influenzae and their use - Google Patents

Polypeptides and polynucleodides from haemophilus influenzae and their use Download PDF

Info

Publication number
WO2002034768A3
WO2002034768A3 PCT/EP2001/012390 EP0112390W WO0234768A3 WO 2002034768 A3 WO2002034768 A3 WO 2002034768A3 EP 0112390 W EP0112390 W EP 0112390W WO 0234768 A3 WO0234768 A3 WO 0234768A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
polynucleodides
haemophilus influenzae
basb204
influenzae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/012390
Other languages
French (fr)
Other versions
WO2002034768A2 (en
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to EP01988726A priority Critical patent/EP1328640A2/en
Priority to AU2002221759A priority patent/AU2002221759A1/en
Priority to CA002426887A priority patent/CA2426887A1/en
Publication of WO2002034768A2 publication Critical patent/WO2002034768A2/en
Publication of WO2002034768A3 publication Critical patent/WO2002034768A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The invention provides H. influenzae BASB204 polypeptides and polynucleotides encoding BASB204 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses.
PCT/EP2001/012390 2000-10-24 2001-10-24 Polypeptides and polynucleodides from haemophilus influenzae and their use Ceased WO2002034768A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01988726A EP1328640A2 (en) 2000-10-24 2001-10-24 Polypeptides and polynucleotides from haemophilus influenzae and their use
AU2002221759A AU2002221759A1 (en) 2000-10-24 2001-10-24 Polypeptides and polynucleodides from haemophilus influenzae and their use
CA002426887A CA2426887A1 (en) 2000-10-24 2001-10-24 Polypeptides and polynucleodides from haemophilus influenzae and their use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0026002.6 2000-10-24
GBGB0026002.6A GB0026002D0 (en) 2000-10-24 2000-10-24 Novel compounds

Publications (2)

Publication Number Publication Date
WO2002034768A2 WO2002034768A2 (en) 2002-05-02
WO2002034768A3 true WO2002034768A3 (en) 2003-01-23

Family

ID=9901867

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/012390 Ceased WO2002034768A2 (en) 2000-10-24 2001-10-24 Polypeptides and polynucleodides from haemophilus influenzae and their use

Country Status (5)

Country Link
EP (1) EP1328640A2 (en)
AU (1) AU2002221759A1 (en)
CA (1) CA2426887A1 (en)
GB (1) GB0026002D0 (en)
WO (1) WO2002034768A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1923399A1 (en) * 2003-03-06 2008-05-21 Children's Hospital, Inc. Genes of an otitis media isolate of nontypeable Haemophilus influenzae
CA2796381A1 (en) * 2003-03-06 2004-09-16 Children's Hospital, Inc. Genes of an otitis media isolate of nontypeable haemophilus influenzae
GB0410866D0 (en) 2004-05-14 2004-06-16 Chiron Srl Haemophilius influenzae
EP1863836B1 (en) * 2005-03-18 2012-07-11 Novozymes Adenium Biotech A/S Polypeptides having antimicrobial activity and polynucleotides encoding same
CA2871088A1 (en) 2005-06-16 2006-12-28 Lauren O. Bakaletz Genes of an otitis media isolate of nontypeable haemophilus influenzae

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000043519A2 (en) * 1999-01-22 2000-07-27 Smithkline Beecham Biologicals S.A. Neisseria meningitidis polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000043519A2 (en) * 1999-01-22 2000-07-27 Smithkline Beecham Biologicals S.A. Neisseria meningitidis polypeptides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EBI / EMBL [online] 31 July 2001 (2001-07-31), DAVIS ET AL: "Haemophilus influenzae Lav (lav) gene, partial cds.", XP002210822, retrieved from EBI / EMBL accession no. AF385403 Database accession no. AF385403 *
DATABASE EBI / EMBL [online] 5 September 1995 (1995-09-05), JENNINGS ET AL: "Neisseria meningitidis LPS-heptosyl-2-transferase (lsi1) gene, complete cds", XP002210886, retrieved from EBI / EMBL accession no. U23782 Database accession no. U23782 *
DAVIS ET AL: "Evolution of an autotransporter: domain shuffling and lateral transfer from pathogenic Haemophilus to Neisseria", JOURNAL OF BACTERIOLOGY, vol. 183, no. 15, August 2001 (2001-08-01), XP002210821 *

Also Published As

Publication number Publication date
EP1328640A2 (en) 2003-07-23
CA2426887A1 (en) 2002-05-02
GB0026002D0 (en) 2000-12-13
AU2002221759A1 (en) 2002-05-06
WO2002034768A2 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
WO1999058562A3 (en) Novel compounds
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
WO1999058683A3 (en) BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS)
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
WO2000043519A3 (en) Neisseria meningitidis polypeptides
WO2002088361A3 (en) Haemophilus influenzae antigens
WO2002030971A3 (en) Basb205 polypeptides and polynucleotides coding therefor
WO1999064602A3 (en) Moraxella catarrhalis polynucleotides and polypeptides
WO2002030960A3 (en) Polypeptide from haemophilus influenza
WO2003055905A3 (en) Proteins of non typable haemophilus influenzae
WO2002034778A3 (en) Baseb209 polypeptides and polynucleotides from haemophilus influenzae
WO2002024729A3 (en) Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use
HK1047943A1 (en) Moraxella cattarrhalis basb114 antigens and uses thereof
WO2000071724A3 (en) Novel compounds from moraxella catarrhalis
WO2002034772A3 (en) Novel compounds
WO2003010195A3 (en) Novel compounds
WO2002066503A3 (en) H. influenzae antigen basb213
GB9918208D0 (en) Novel compounds
WO2002030967A3 (en) Novel compounds
WO2002060938A3 (en) Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof
WO2002032945A3 (en) Haemophilus influenzae basb206 gene and protein
WO2002088360A3 (en) Haemophilus influenzae antigens
WO2002079237A3 (en) Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
WO2002100891A3 (en) Proteins derived from non-typable haemophilus influenzae (nthi) strain
WO2002046215A3 (en) Basb221 polypeptides and polynucleotides encoding basb221 polypeptides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2426887

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001988726

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001988726

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001988726

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP